Literature DB >> 15865499

Electroacupuncture provides a new approach to neuroprotection in rats with induced glaucoma.

Henry H L Chan1, Mason C P Leung, Kwok-Fai So.   

Abstract

OBJECTIVES: To investigate, using multifocal electroretinogram (mfERG), the effect of electroacupuncture (EA) on retinal function in rats with experimental glaucoma. DESIGN AND
SUBJECTS: Glaucoma was induced in the right eyes of 15 adult female Sprague-Dawley rats by laser photocoagulation for three quarters of the perilimbal and episcleral vessels. The left eye of each rat was used as the control. The animals were divided into 3 groups: no treatment (non-EA control group), 2 Hz EA group, and 100 Hz EA group. EA treatment at different frequencies can produce different levels of analgesia and hence the effect of EA with different frequencies on glaucoma treatment was investigated. Both eyes of each rat in the EA experimental groups received 3 EA treatment sessions each week for 4 weeks. The retinal function was measured using mfERG after 4 weeks of EA treatment.
RESULTS: There was no significant difference in the amplitude (both N1 trough and P1 peak) of mfERG firstorder kernel response between the treatment and control groups. In determining the waveform characteristics by the ratio of N1 amplitude to P1 amplitude (N/P ratio), obvious differences were found in the N/P ratio between the control eyes and the glaucoma eyes in the non-EA group and the 100 Hz EA treatment group, but similar values in the N/P ratio were observed between the control eyes and the glaucoma eyes in the 2 Hz EA treatment group. The waveform from the eyes with glaucoma was deformed in both the non-EA group and the 100 Hz EA group, but the waveform from the glaucomatous eye was preserved in the 2 Hz EA group.
CONCLUSIONS: Application of EA at 2 Hz provides neuroprotection by preserving retinal function in rats with experimental glaucoma. Low frequency EA may be an alternative therapy in the treatment of glaucoma.

Entities:  

Mesh:

Year:  2005        PMID: 15865499     DOI: 10.1089/acm.2005.11.315

Source DB:  PubMed          Journal:  J Altern Complement Med        ISSN: 1075-5535            Impact factor:   2.579


  8 in total

Review 1.  Acupuncture for glaucoma.

Authors:  Simon K Law; Tianjing Li
Journal:  Cochrane Database Syst Rev       Date:  2013-05-31

2.  Electroacupuncture Improves Choroidal Blood Flow to Inhibit the Development of Lens-Induced Myopia in Guinea Pigs.

Authors:  Ting Yu; Xiaofeng Xie; Huixia Wei; Qiuxin Wu; Xiuyan Zhang; Qingmei Tian; Jike Song; Hongsheng Bi
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-24       Impact factor: 2.650

Review 3.  Acupuncture for glaucoma.

Authors:  S K Law; T Li
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

4.  Acupuncture for glaucoma.

Authors:  Simon K Law; Lin Wang; Tianjing Li
Journal:  Cochrane Database Syst Rev       Date:  2020-02-07

5.  Effect of lycium barbarum (wolfberry) polysaccharides on preserving retinal function after partial optic nerve transection.

Authors:  Patrick H W Chu; Hong-Ying Li; Man-Pan Chin; Kwok-fai So; Henry H L Chan
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

6.  Early electroacupuncture treatment ameliorates neuroinflammation in rats with traumatic brain injury.

Authors:  Wei-Chen Tang; Yao-Chin Hsu; Che-Chuan Wang; Chiao-Ya Hu; Chung-Ching Chio; Jinn-Rung Kuo
Journal:  BMC Complement Altern Med       Date:  2016-11-16       Impact factor: 3.659

7.  Acupuncture for rehabilitation after surgery for cerebellopontine angle meningioma: A case report.

Authors:  Dexiong Han; Yejing Shen; Hantong Hu; Ying Zhang; Xingling Li; Lianqiang Fang; Hong Gao
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

8.  Methods to Induce Chronic Ocular Hypertension: Reliable Rodent Models as a Platform for Cell Transplantation and Other Therapies.

Authors:  Ashim Dey; Abby L Manthey; Kin Chiu; Chi-Wai Do
Journal:  Cell Transplant       Date:  2018-02       Impact factor: 4.064

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.